Back

Combined effects of gamma-glutamyltransferase and high-sensitivity C-reactive protein on cardiovascular events in patients with diabetes and chronic coronary syndrome

26 April 2024 (13:21 - 13:33)
Organised by: Logo
Congress Presentation Part of: Effectively managing cardiovascular risk in Type 2 diabetes Epidemiology, Prognosis, Outcome Open Access ESC Preventive Cardiology 2024 European Association of Preventive Cardiology (EAPC)

About the speaker

Photo
Doctor Tianyu Li

Fuwai Hospital, Beijing (China)

4 More presentations in this session

Presentation thumbnail
Quiz presentation
Doctor S. Gati (London, GB) Professor V. Vassiliou (Norwich, GB)
Slides Video
Presentation thumbnail
Effects of urinary tract infection and stopping sodium-glucose cotranspoter-2 inhibitors in patients with type 2 diabetes mellitus: a population-based study
Professor Y. Kai Hang (Shenzhen, CN)
Abstract Slides
Presentation thumbnail
Potentially avoidable hospitalizations for diabetes in Switzerland
Doctor K. Maung (Lausanne, CH)
Abstract Slides Video
Presentation thumbnail
Diabetic ketoacidosis in patients with type 2 diabetes mellitus receiving sodium-glucose co-transporter-2 inhibitors: The Hong Kong Diabetes Study
Professor G. Tse (Hong Kong, CN)
Abstract Slides

Access the full session

Session thumbnail
Effectively managing cardiovascular risk in Type 2 diabetes

The Event

Event poster

ESC Preventive Cardiology 2024

26 April 2024 13:21 CET
You may be interested in
thumbnail
Congress Session
Novel biomarkers for cardiovascular risk prediction
thumbnail
Congress Session
Secondary prevention: biomarkers to optimise outcomes
thumbnail
Congress Presentation
C-reactive protein and cardiovascular risk in the general population

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources